Compare SANA & EZPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SANA | EZPW |
|---|---|---|
| Founded | 2018 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | 2021 | 1996 |
| Metric | SANA | EZPW |
|---|---|---|
| Price | $3.15 | $26.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | $7.50 | ★ $24.00 |
| AVG Volume (30 Days) | ★ 1.8M | 865.2K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 17.24 | ★ 29.09 |
| EPS | N/A | ★ 0.55 |
| Revenue | N/A | ★ $747,954,000.00 |
| Revenue This Year | N/A | $24.85 |
| Revenue Next Year | N/A | $11.13 |
| P/E Ratio | ★ N/A | $48.09 |
| Revenue Growth | N/A | ★ 2.39 |
| 52 Week Low | $1.27 | $12.89 |
| 52 Week High | $6.55 | $27.30 |
| Indicator | SANA | EZPW |
|---|---|---|
| Relative Strength Index (RSI) | 31.91 | 57.81 |
| Support Level | $2.85 | $20.65 |
| Resistance Level | $3.24 | $26.35 |
| Average True Range (ATR) | 0.26 | 0.90 |
| MACD | -0.08 | -0.13 |
| Stochastic Oscillator | 6.42 | 56.16 |
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.
EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buys and sells second-hand goods. The operating segments of the company are U.S. Pawn, Latin America Pawn, and Other Investments. The U.S. Pawn segment includes all pawn activities in the United States. The Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales, which are mainly collateral forfeited from pawn lending operations and used merchandise purchased from the customers.